There is a growing concern in Britain over clinical trials of a plant-based drug called galanthamine hydrobromide, now being tested to see whether it can help people suffering from chronic fatigue syndromes. Some health experts fear that the drug could be dangerous for many people with this condition and could increse the severity of their symptoms.